Why the study?
Does enalapril improve blood pressure in children age 6 to 16 years with hypertension?
Does enalapril improve blood pressure in children age 6 to 16 years with hypertension?
Enalapril is well tolerated as an antihypertensive therapy in children aged 6 to 16 years.
Answers are grounded in this paper and cite their sources.
Enalapril is well tolerated short-term in hypertensive children 6-16 years; extends pediatric ACEI safety data but leaves BP efficacy open.
This study assessed the antihypertensive efficacy and safety of enalapril in children with hypertension age 6 to 16 years. After up to one week washout from prior antihypertensive therapy, patients with trough sitting diastolic BP > 95th percentile for gender, age and height were randomized to receive 1 of 3 enalapril treatments once daily for 14 days: 0.625/1.25 mg, 2.5/5 mg, or 20/40 mg. Patients who weighed <50 kg received the lower dose in the respective treatment groups (0.625, 2.5, or 20 mg), and patients who weighed ≥50 kg received the higher dose (1.25, 5, or 50 mg). Patients in the 20/40 mg group received a half dose for the first 2 days, then were titrated to the full dose. After 2 weeks of double-blind therapy, patients entered a randomized washout period and either continued on their current study regimen or switched to placebo for up to 2 weeks or when their blood pressure returned to baseline which ever came first. This is the first and largest double-blind, controlled study completed in children with hypertension. Enalapril was well tolerated by these children.
No takes yet. Share an insight, caveat, or question.
Beth A. Soffer (2000) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: